Navigation Links
Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)
Date:5/31/2008

- Results Confirm Previously Demonstrated Survival Advantages of Tarceva in

This Difficult-to-Treat Disease

- ABSTRACT No: 4507

BASEL, Switzerland, May 31 /PRNewswire/ -- Adding Avastin (bevacizumab) to a combination of Tarceva (erlotinib) and chemotherapy significantly improves the time patients with metastatic pancreatic cancer live without their disease getting worse ("progression free survival"). These data, presented for the first time today at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, also showed a trend towards extending life expectancy.

Pancreatic cancer is the sixth leading cause of cancer death in Europe(1) and is extremely difficult to treat because it spreads rapidly to other parts of the body and often shows resistance to chemotherapy and radiotherapy(2). It is also difficult to diagnose, with no effective early diagnostic test available(3) so the majority of patients are diagnosed with advanced disease.

"For patients with advanced pancreatic cancer, the treatment options are limited," commented Professor Eric Van Cutsem, Professor of Medicine, Gastrointestinal Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. "The interesting results show the need for further exploring which patients benefit from the combination of gemcitabine plus Avastin and Tarceva in view of the statistically longer PFS which trends towards improved survival."

The results of the phase III AVITA (BO17706) study showed that the addition of Avastin to a Tarceva/gemcitabine combination resulted in:

- A 37% increase in the time patients live without their disease getting

worse compared to Tarceva/gemcitabine alone

- Almost 14% of patients experiencing a complete disappearance or

shrinkage of their tumor

- A trend towards improved overall survival

- No new safety signals for Avastin

In
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
2. New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
3. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
4. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
5. Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
6. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
7. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
8. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
9. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
10. Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
11. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015   Decision Resources Group ... Europe will continue to be hindered ... the Eurozone. On a longer timeline, however, the outlook ... physically active will increase the prevalence of osteoarthritic damage ... and orthopedic soft tissue solutions. Coupled with continuing economic ...
(Date:7/29/2015)... REDMOND, Washington , 29. Juli 2015 ... deutschen Diabeteszentrums wurde festgestellt, dass die tägliche ... von Nutraceutix die menschliche Darmflora anreichert und ... Insulinsekretion erhöhen. Die Studie umfasste die tägliche ... (ATCC-Stamm SD-5865) in Tablettenform unter Verwendung der ...
(Date:7/29/2015)... INCLINE VILLAGE, Nev. , July 29, 2015 /PRNewswire/ ... that it has entered into a revenue interest assignment ... provide ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA ) with ... exchange for royalties on the net revenues of Iclusig ... will be made in two tranches of $50 million ...
Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5
... Day Schedule -- SHANGHAI, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Treatment TMC278 -- CORK, Ireland, September 3, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
Cached Medicine Technology:China-Biotics Announces September 20 Investor Day Schedule 2China-Biotics Announces September 20 Investor Day Schedule 3China-Biotics Announces September 20 Investor Day Schedule 4China-Biotics Announces September 20 Investor Day Schedule 5China-Biotics Announces September 20 Investor Day Schedule 6China-Biotics Announces September 20 Investor Day Schedule 7Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 2Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 3Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 4Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 5Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 6Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 7Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 8
(Date:7/29/2015)... ... 2015 , ... Gender minority people who are transgender or ... provided legal protections against discrimination on the basis of gender identity in employment, ... based on gender identity in places open to the public, such as transportation, ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... get organized. , Wouldn’t it be great if everyone could be a little more ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Join Luz Delia ... healthfulness. Gerber believes that Well-Being begins with understanding how the body actually works. A ... of healthfulness within. Guests will receive tips on how to forge this new relationship ...
(Date:7/29/2015)... ... ... Ticket Down is a reliable source of authentic tickets for the international ... The international soccer schedule of matches played on American soil continues to grow each ... the world’s greatest teams, Brazil, will travel to North America to compete with the ...
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... ... (the Commission) CCM® credential for a five-year period, expiring November 30, 2019, during ... CCM credential by submitting an application demonstrating the program’s compliance with the NCCA’s ...
Breaking Medicine News(10 mins):Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Get More Organized with the Core Organizer App 2Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3
... Quality,Respiratory Care (CQRC) expressed extreme concern and disappointment ... for Medicare and Medicaid,Services (CMS) implementing the Deficit ... oxygen therapy. With the January 1, 2009,implementation date ... guidance on how Medicare will cover the costs ...
... new report shows many are cutting,back on health ... ways to get the,most out of your health ... Listen to this report from CIGNA at:, ... audio, text, graphics and,photos for free and unrestricted ...
... hair cells from pumping out excess calcium, study finds , , ... that mimics progressive hearing loss in humans has been identified ... mutation in a gene called Oblivion had problems with the ... with one mutant copy of the Oblivion gene, ear hair ...
... increases in surgical capacity or diverting patients to other ... wait times for hip and knee replacement surgery ... , Politically popular strategies, such ... much impact, according to a new study. Instead, the ...
... where people have to opt out of donating their organs when ... waiting list for transplant. , That is the opinion of Dr ... of body parts, who has recently joined the University of Bath,s ... patients in the UK currently on the waiting list for organ ...
... Impact of McCain, Obama,Proposals, WASHINGTON, Oct. 31 ... and costs are continuing to skyrocket --,making health care ... United States., A detailed analysis of each candidate,s ... government is included in the Guide to,Healthcare: The 2008 ...
Cached Medicine News:Health News:Council for Quality Respiratory Care Statement 2Health News:Mutant Mouse Gene Offers Clues to Hearing Loss 2Health News:Wait time guarantees not likely to reduce waits for joint replacement surgery 2Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Candidates' Proposals to Address Health Care Cost, Coverage and Quality Come at Major Costs 2Health News:Candidates' Proposals to Address Health Care Cost, Coverage and Quality Come at Major Costs 3
... Thalia eyeglasses eyewear collection reflects ... of the renowned Latin singer/actress ... eyeglasses eyewear is ultra-sleek, fashionable, ... styles that include decorative details ...
... Vera Wang Eyewear, a dainty, feminine collection ... launched in the UK by The Norville ... sensuous curves of Vera Wang Eyewear bring ... fine quality materials such as stainless steel, ...
... care is something that almost all retailers ... these needs with VALUE - not just ... design. Jobson Research shows that National is ... care product., ,National offers an exciting collection ...
... Eyewear Collection reflects the ... elegance, refinement and comfort ... dedication to quality and ... of the Lacoste brand, ...
Medicine Products: